Výsledky vyhledávání - "Hepacivirus/classification"

Prevalence of Equine Hepacivirus Infections in France and Evidence for Two Viral Subtypes Circulating Worldwide

Autor: Stéphane Pronost, Eric Richard, Félix A. Rey, Guillaume Fortier, F. Desbrosse, Marc Foursin, Pierre-Hugues Pitel, Christine Fortier, Erika Hue, Bertrand Saunier

Publikováno v: Transboundary and emerging diseases
Transboundary and emerging diseases, 2017, 64 (6), pp.1884-1897. ⟨10.1111/tbed.12587⟩
Transboundary and emerging diseases, Wiley-Blackwell, 2017, 64 (6), pp.1884-1897. ⟨10.1111/tbed.12587⟩

International audience; Like hepatitis C virus (HCV) in humans, the newly identified equine hepacivirus (NPHV) displays a predominating liver tropism that may evolve into chronic infections. The genomes of the two viruses share several organizational

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::58cb6583712d1bf6f415d409f40217bf
https://doi.org/10.1111/tbed.12587

Zobrazit plný text záznamu

Prevalence of NS5A resistance associated substitutions in patients with hepatitis C virus genotypes 1a and 3: Impact on current therapeutic strategies

Autor: Marta Grandal, Álvaro Mena, Manuel Delgado, Berta Pernas, Ana Mariño, Hortensia Álvarez, Nieves Valcarce, Ana B. Pérez, Eva Poveda, Andrés Tabernilla, Ángeles Castro-Iglesias

Publikováno v: RUC. Repositorio da Universidade da Coruña
instname

[Abstract] The presence of resistance‐associated substitutions (RASs) at NS5A region might compromise the efficacy of Direct Acting Antiviral agents (DAAs). HCV resistance at NS5A region is mainly focused on patients with hepatitis C virus (HCV) ge

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2aad7b092ae15cd93d4287eb797adb38
https://hdl.handle.net/2183/20798

Zobrazit plný text záznamu

STARTVerso1: A Randomized Trial of Faldaprevir Plus Pegylated Interferon/Ribavirin for Chronic HCV Genotype-1 Infection

Publikováno v: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Agência para a Sociedade do Conhecimento (UMIC)-FCT-Sociedade da Informação
instacron:RCAAP
Ferenci, Peter; Asselah, Tarik; Foster, Graham R; Zeuzem, Stefan; Sarrazin, Christoph; Moreno, Christophe; Ouzan, Denis; Maevskaya, Marina; Calinas, Filipe; Morano, Luis E; Crespo, Javier; Dufour, Jean-François; Bourlière, Marc; Agarwal, Kosh; Forton, Daniel; Schuchmann, Marcus; Zehnter, Elmar; Nishiguchi, Shuhei; Omata, Masao; Kukolj, George; ... (2015). STARTVerso1: A randomized trial of faldaprevir plus pegylated interferon/ribavirin for chronic HCV genotype-1 infection. Journal of hepatology, 62(6), pp. 1246-1255. Elsevier 10.1016/j.jhep.2014.12.024

BACKGROUND & AIMS The efficacy and tolerability of faldaprevir, a potent hepatitis C virus (HCV) NS3/4A protease inhibitor, plus peginterferon and ribavirin was assessed in a double-blind, placebo-controlled phase 3 study of treatment-naïve patients

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48feb1ddd3b1a0089ca2b28b5256ec41

Zobrazit plný text záznamu

Ledipasvir-sofosbuvir with or without ribavirin to treat patients with HCV genotype 1 infection and cirrhosis non-responsive to previous protease-inhibitor therapy: a randomised, double-blind, phase 2 trial (SIRIUS)

Publikováno v: The Lancet Infectious Diseases
The Lancet Infectious Diseases, New York, NY : Elsevier Science ; The Lancet Pub. Group, 2001-, 2015, 15 (4), pp.397-404. ⟨10.1016/S1473-3099(15)70050-2⟩
The Lancet Infectious Diseases, 2015, 15 (4), pp.397-404. ⟨10.1016/S1473-3099(15)70050-2⟩
The Lancet Infectious Diseases, New York, NY : Elsevier Science ; The Lancet Pub. Group, 2001-, 2015, 15 (4), pp.397-404. 〈10.1016/S1473-3099(15)70050-2〉

Summary Background Patients with cirrhosis resulting from chronic hepatitis C virus (HCV) infection are at risk of life-threatening complications, but consistently achieve lower sustained virological response (SVR) than patients without cirrhosis, es

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2cb0f598ef5688abbcb07c6ae6c6f530
https://hal-univ-rennes1.archives-ouvertes.fr/hal-01134440

Zobrazit plný text záznamu

Molecular Characterization of Human Immunodeficiency Virus Type 1 and Hepatitis C Virus in Paid Blood Donors and Injection Drug Users in China

Autor: Jian Yu, Zhiwei Chen, Peter Balfe, Yun-Zhen Cao, Li Li, Ning Yin, Man-Fung Yuen, Linqi Zhang, Tian He, Shan Mei, David D. Ho, His-Hsun Lin, Ching-Lung Lai, Lei Ba, Fengwen Zhang, Wenjie Yu, Guanghan Li

Publikováno v: Journal of Virology. 78:13591-13599

China is facing a rapid upsurge in cases of human immunodeficiency virus type 1 (HIV-1) and hepatitis C virus (HCV) infection due to large numbers of paid blood donors (PBD), injection drug users (IDU), and sexual partners of infected individuals. In

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a3268a4e9b7624604d621f11604ac558
https://doi.org/10.1128/jvi.78.24.13591-13599.2004

Zobrazit plný text záznamu

Marokko hat in den letzten Jahrzehnten eine Drift von zirkulierenden Hepatitis-C-Virus-Subtypen erlebt

Autor: Brahim, Ikram, Akil, Abdelah, Mtairag, El Mostafa, Pouillot, Régis, Malki, Abdelouhad El, Nadir, Salwa, Alaoui, Rhimou, Njouom, Richard, Pineau, Pascal, Ezzikouri, Sayeh, Benjelloun, Soumaya

Publikováno v: Archives of Virology
Archives of Virology, 2012, 157 (3), pp.515-520. ⟨10.1007/s00705-011-1193-7⟩

International audience; Hepatitis C virus (HCV) isolates circulating in Morocco are poorly documented. To determine the subgenotype distribution of HCV in chronically infected patients, serum samples from 185 anti-HCV-positive patients were analyzed.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______1398::a0f2a2722809e1557318762023a656e4
https://hal-pasteur.archives-ouvertes.fr/pasteur-02863328

Zobrazit plný text záznamu

Morocco underwent a drift of circulating hepatitis C virus subtypes in recent decades

Autor: Soumaya Benjelloun, Salwa Nadir, Abdellah Akil, Abdelouhad El Malki, Sayeh Ezzikouri, Pascal Pineau, Rhimou Alaoui, Régis Pouillot, El Mostafa Mtairag, Ikram Brahim, Richard Njouom

Publikováno v: Archives of Virology
Archives of Virology, 2012, 157 (3), pp.515-520. ⟨10.1007/s00705-011-1193-7⟩
Archives of Virology, Springer Verlag, 2012, 157 (3), pp.515-520. ⟨10.1007/s00705-011-1193-7⟩

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::578227c9f17d2535b671742b7b74007a
https://hal-pasteur.archives-ouvertes.fr/pasteur-02863328

Zobrazit plný text záznamu

A novel hepatitis C virus (HCV) subtype from Somalia and its classification into HCV clade 3

Autor: Antoine Hadengue, Rafael Quadri, Karim Abid, Francesco Negro, Anne-Lise Veuthey

Publikováno v: The Journal of general virology, vol. 81, no. Pt 6, pp. 1485-1493
Journal of General Virology, Vol. 81, No 6 (2000) pp. 1485-1493

Hepatitis C virus (HCV) sequences from throughout the world have been grouped into six clades, based on recently proposed criteria. Here, the partial sequences and clade assignment are reported for three HCV isolates from chronic hepatitis C patients

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a5115b83c8d17ea70a5100856d16841
https://pubmed.ncbi.nlm.nih.gov/10811932

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání